Harvard Bioscience Inc (HBIO) Reports Mixed Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]
Harvard Bioscience, Inc. (HBIO)
Last harvard bioscience, inc. earnings: 2/26 07:15 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.harvardbioscience.com
Company Research
Source: Yahoo! Finance
Gross Margin : Improved to 58.9% for the full year, up from 53.7% in the previous year. Operating Income : Q4 GAAP operating income at $0.3 million, full-year adjusted operating income increased to $13.1 million. Net Loss : Q4 net loss widened to $(1.8) million, full-year net loss improved to $(3.4) million from $(9.5) million. Adjusted EBITDA : Q4 remained stable at $3.6 million, full-year rose to $14.6 million from $10.8 million. Debt Reduction : Reduced by $10.5 million during the year, with net leverage ratio improving from 4.0 to 2.3. Warning! GuruFocus has detected 3 Warning Signs with HBIO. On March 7, 2024, Harvard Bioscience Inc ( NASDAQ:HBIO ) released its 8-K filing , announcing the financial results for the fourth quarter and the full year ended December 31, 2023. The company, a global developer, manufacturer, and seller of technologies for life science research and pre-clinical testing, faced a modest revenue decline in a challenging Asia-Pacific (APAC) marke
Show less
Read more
Impact Snapshot
Event Time:
HBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HBIO alerts
High impacting Harvard Bioscience, Inc. news events
Weekly update
A roundup of the hottest topics
HBIO
News
- Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth [Yahoo! Finance]Yahoo! Finance
- Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in GrowthGlobeNewswire
- Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
- Investing in Harvard Bioscience (NASDAQ:HBIO) a year ago would have delivered you a 25% gain [Yahoo! Finance]Yahoo! Finance
- Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference [Yahoo! Finance]Yahoo! Finance
HBIO
Earnings
- 3/7/24 - Beat
HBIO
Sec Filings
- 4/3/24 - Form ARS
- 4/3/24 - Form DEFA14A
- 4/3/24 - Form DEF
- HBIO's page on the SEC website